Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

387 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas

NCT01744249

Conditions
Advanced Cancer, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations
  • Marburg Universitätsklinikum Giessen und Marburg GmbH Marburg, Germany
  • Azienda Ospedaliera Universitaria di Perugia Perugia, Italy
  • Sapienza, Universitá di Roma, Ospedale sant'Andrea Rome, Italy
  • Institut Català d'Oncologia L'Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
View all 26 locations
View Trial Details
Completed

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

NCT05361668

Conditions
Adenocarcinoma, Carcinoid, Carcinoid Intestine Tumor, +19 more
Locations
  • Crinetics Study Site Los Angeles, California, United States
  • Crinetics Study Site Los Angeles, California, United States
  • Crinetics Study Site Newport Beach, California, United States
  • Crinetics Study Site Stanford, California, United States
View all 35 locations
View Trial Details
Completed

MGMT-NET: O6-methylguanine-DNA Methyltransferase (MGMT) Status in Neuroendocrine Tumors: Predictive Factor of Response to Alkylating Agents

NCT03217097

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Hôpital Sud - CHU Amiens Amiens, France
  • CHU d'Angers Angers, France
  • Hôpital Estaing, CHU de Clermont-Ferrand Clermont-Ferrand, France
  • Hôpital Beaujon - APHP Clichy, France
View all 19 locations
View Trial Details
Completed

EchoTip AcuCore Post-Market Clinical Study

NCT06358001

Conditions
Adenocarcinoma, Autoimmune Diseases, Autoimmune Pancreatitis, +34 more
Locations
  • University of California, Irvine Orange, California, United States
  • Advent Health, Porter Denver, Colorado, United States
  • Shands Hospital-University of Florida Gainesville, Florida, United States
  • University of Florida Shands Hospital Gainesville, Florida, United States
View Trial Details
Completed

Open-label Study of Surufatinib in Japanese Patients

NCT05077384

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations
  • Kyushu University Hospital Fukuoka, Japan
  • Fukuoka Sanno Hospital Fukuoka, Japan
  • Kagawa University Hospital Kagawa, Japan
  • National Cancer Centre Hospital East Kashiwa-shi, Japan
View Trial Details

Related conditions